Literature DB >> 23291388

Interleukin-1 receptor antagonist in refractory haemochromatosis-related arthritis of the hands.

Augustin Latourte, Aline Frazier, Claire Brière, Hang-Korng Ea, Pascal Richette.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23291388     DOI: 10.1136/annrheumdis-2012-202738

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  7 in total

1.  Novel Piperazino-Enaminones Decrease Pro-inflammatory Cytokines Following Hemarthrosis in a Hemophilia Mouse Model.

Authors:  Chen Zhong; Doreen Szollosi; Junjiang Sun; Baolai Hua; Ola Ghoneim; Ashley Bill; Yingping Zhuang; Ivan Edafiogho
Journal:  Inflammation       Date:  2019-10       Impact factor: 4.092

Review 2.  An expanding role for interleukin-1 blockade from gout to cancer.

Authors:  Charles Anthony Dinarello
Journal:  Mol Med       Date:  2014-12-16       Impact factor: 6.354

Review 3.  [Hemochromatosis].

Authors:  B Oppl; J Zwerina
Journal:  Z Rheumatol       Date:  2015-09       Impact factor: 1.372

Review 4.  Interleukin-1 function and role in rheumatic disease.

Authors:  Georg Schett; Jean-Michel Dayer; Bernhard Manger
Journal:  Nat Rev Rheumatol       Date:  2015-12-10       Impact factor: 20.543

Review 5.  HFE-related hemochromatosis: an update for the rheumatologist.

Authors:  Emma Husar-Memmer; Andreas Stadlmayr; Christian Datz; Jochen Zwerina
Journal:  Curr Rheumatol Rep       Date:  2014-01       Impact factor: 4.592

Review 6.  Treating inflammation by blocking interleukin-1 in humans.

Authors:  Charles A Dinarello; Jos W M van der Meer
Journal:  Semin Immunol       Date:  2013-11-23       Impact factor: 11.130

Review 7.  Treatment of nongout joint deposition diseases: an update.

Authors:  Tristan Pascart; Pascal Richette; René-Marc Flipo
Journal:  Arthritis       Date:  2014-05-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.